NoMs - أخبار الطب والصحة

News of Medics

Tuesday, July 27, 2021

تُظهر البيانات الإسرائيلية أن لقاح Covid التجريبي من شركة Pfizer فعال بنسبة 39٪ فقط مع انتشار "دلتا".

 


at July 27, 2021 No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Search This Blog

Blog Archive

  • ►  2025 (33)
    • ►  July (2)
    • ►  June (4)
    • ►  May (9)
    • ►  April (5)
    • ►  March (1)
    • ►  February (9)
    • ►  January (3)
  • ►  2024 (12)
    • ►  November (2)
    • ►  October (3)
    • ►  September (1)
    • ►  June (1)
    • ►  April (1)
    • ►  January (4)
  • ►  2023 (16)
    • ►  December (3)
    • ►  November (2)
    • ►  September (1)
    • ►  July (3)
    • ►  June (3)
    • ►  May (1)
    • ►  April (1)
    • ►  February (2)
  • ►  2022 (42)
    • ►  December (1)
    • ►  October (2)
    • ►  September (3)
    • ►  August (6)
    • ►  July (2)
    • ►  June (3)
    • ►  May (6)
    • ►  March (3)
    • ►  February (6)
    • ►  January (10)
  • ▼  2021 (76)
    • ►  December (11)
    • ►  November (2)
    • ►  October (5)
    • ►  September (4)
    • ▼  July (1)
      • تُظهر البيانات الإسرائيلية أن لقاح Covid التجريبي ...
    • ►  June (8)
    • ►  May (9)
    • ►  April (8)
    • ►  March (7)
    • ►  February (9)
    • ►  January (12)
  • ►  2020 (53)
    • ►  December (5)
    • ►  November (15)
    • ►  October (12)
    • ►  September (2)
    • ►  August (4)
    • ►  June (3)
    • ►  March (1)
    • ►  January (11)
  • ►  2019 (6)
    • ►  December (2)
    • ►  October (1)
    • ►  August (3)

Popular Posts

  • How many types of Medical Doctors?
     
  • مسار الإخصاب .... حيوان منوي واحد يفوز في نهابة المطاف بعد سباق الحواجز Sperm trophy
     
  • Neuralink's implant is intended to help people with spinal cord injuries
      Neuralink's implant is intended to help people with spinal cord injuries. The device has allowed the first patient to play video games...
Picture Window theme. Theme images by loops7. Powered by Blogger.